Works matching AU Rekić, Dinko

Results: 22

Dapagliflozin Pharmacokinetics Is Similar in Adults With Type 1 and Type 2 Diabetes Mellitus.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 10, p. 1227, doi. 10.1002/jcph.2062

By:

Melin, Johanna;
Tang, Weifeng;
Rekić, Dinko;
Hamrén, Bengt;
Penland, Robert C.;
Boulton, David W.;
Parkinson, Joanna

Publication type:

Article

QT Prolongation Risk Assessment in Oncology: Lessons Learned From Small‐Molecule New Drug Applications Approved During 2011‐2019.

Published in:

Journal of Clinical Pharmacology, 2021, v. 61, n. 8, p. 1106, doi. 10.1002/jcph.1844

By:

Cohen‐Rabbie, Sarit;
Berges, Alienor C.;
Rekić, Dinko;
Parkinson, Joanna;
Dota, Corina;
Tomkinson, Helen K.

Publication type:

Article

A case‐study of model‐informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 12, p. 1569, doi. 10.1002/psp4.12866

By:

Knöchel, Jane;
Nilsson, Catarina;
Carlsson, Björn;
Wernevik, Linda;
Hofherr, Alexis;
Gennemark, Peter;
Jansson‐Löfmark, Rasmus;
Isaksson, Rikard;
Rydén‐Bergsten, Tina;
Hamrén, Bengt;
Rekić, Dinko

Publication type:

Article

Assumption Checking Before Application of the Prespecified QT Linear Mixed Effect Model is Essential.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 7, p. 371, doi. 10.1002/psp4.12517

By:

Rekić, Dinko;
Parkinson, Joanna;
Kimko, Holly

Publication type:

Article

An oral antisense oligonucleotide for PCSK9 inhibition.

Published in:

Science Translational Medicine, 2021, v. 13, n. 593, p. 1, doi. 10.1126/scitranslmed.abe9117

By:

Gennemark, Peter;
Walter, Katrin;
Clemmensen, Niclas;
Rekić, Dinko;
Nilsson, Catarina A.M.;
Knöchel, Jane;
Hölttä, Mikko;
Wernevik, Linda;
Rosengren, Birgitta;
Kakol-Palm, Dorota;
Wang, Yanfeng;
Yu, Rosie Z.;
Geary, Richard S.;
Riney, Stan J.;
Monia, Brett P.;
Isaksson, Rikard;
Jansson-Löfmark, Rasmus;
Rocha, Cristina S. J.;
Lindén, Daniel;
Hurt-Camejo, Eva

Publication type:

Article

A semi-mechanistic exposure–response model to assess the effects of verinurad, a potent URAT1 inhibitor, on serum and urine uric acid in patients with hyperuricemia-associated diseases.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2021, v. 48, n. 4, p. 525, doi. 10.1007/s10928-021-09747-y

By:

Leander, Jacob;
Sunnåker, Mikael;
Rekić, Dinko;
Aksenov, Sergey;
Eriksson, Ulf G.;
Johansson, Susanne;
Parkinson, Joanna

Publication type:

Article

A disease progression model of longitudinal lung function decline in idiopathic pulmonary fibrosis patients.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2021, v. 48, n. 1, p. 55, doi. 10.1007/s10928-020-09718-9

By:

Bi, Youwei;
Rekić, Dinko;
Paterniti, Miya O.;
Chen, Jianmeng;
Marathe, Anshu;
Chowdhury, Badrul A.;
Karimi-Shah, Banu A.;
Wang, Yaning

Publication type:

Article

Model based design and analysis of phase II HIV-1 trials.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2013, v. 40, n. 4, p. 487, doi. 10.1007/s10928-013-9324-2

By:

Rekić, Dinko;
Röshammar, Daniel;
Simonsson, Ulrika

Publication type:

Article

Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.

Published in:

Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 2, p. 141, doi. 10.1007/s00280-023-04555-2

By:

Någård, Mats;
Ah-See, Mei-Lin;
Strauss, James;
Wise-Draper, Trisha;
Safran, Howard P.;
Nadeau, Laura;
Edenfield, William J.;
Lewis, Lionel D.;
Rekić, Dinko;
Dota, Corina;
Ottesen, Lone H.;
Li, Yan;
Mugundu, Ganesh M.

Publication type:

Article

Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.

Published in:

2017

By:

Paterniti, Miya O.;
Youwei Bi;
Rekić, Dinko;
Yaning Wang;
Karimi-Shah, Banu A.;
Chowdhury, Badrul A.;
Bi, Youwei;
Wang, Yaning

Publication type:

journal article

The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses.

Published in:

Pharmacology Research & Perspectives, 2024, v. 12, n. 2, p. 1, doi. 10.1002/prp2.1184

By:

Parkinson, Joanna;
Sundell, Jesper;
Rekić, Dinko;
Nelander, Karin;
Ericsson, Hans;
Ebrahimi, Ahmad;
Dota, Corina;
Sunnåker, Mikael

Publication type:

Article

In silico prediction of efavirenz and rifampicin drug-drug interaction considering weight and CYP2B6 phenotype.

Published in:

British Journal of Clinical Pharmacology, 2011, v. 71, n. 4, p. 536, doi. 10.1111/j.1365-2125.2010.03883.x

By:

Rekić, Dinko;
Röshammar, Daniel;
Mukonzo, Jackson;
Ashton, Michael

Publication type:

Article

External Validation of the Bilirubin-Atazanavir Nomogram for Assessment of Atazanavir Plasma Exposure in HIV-1-Infected Patients.

Published in:

AAPS Journal, 2013, v. 15, n. 2, p. 308, doi. 10.1208/s12248-012-9440-8

By:

Rekić, Dinko;
Röshammar, Daniel;
Bergstrand, Martin;
Tarning, Joel;
Calcagno, Andrea;
D'Avolio, Antonio;
Ormaasen, Vidar;
Vigan, Marie;
Barrail-Tran, Aurélie;
Ashton, Michael;
Gisslén, Magnus;
Äbelö, Angela

Publication type:

Article

Bilirubin-A Potential Marker of Drug Exposure in Atazanavir-Based Antiretroviral Therapy.

Published in:

AAPS Journal, 2011, v. 13, n. 4, p. 598, doi. 10.1208/s12248-011-9299-0

By:

Rekić, Dinko;
Clewe, Oskar;
Röshammar, Daniel;
Flamholc, Leo;
Sönnerborg, Anders;
Ormaasen, Vidar;
Gisslén, Magnus;
Äbelö, Angela;
Ashton, Michael

Publication type:

Article

Population pharmacokinetics of a novel PCSK9 antisense oligonucleotide.

Published in:

British Journal of Clinical Pharmacology, 2024, v. 90, n. 6, p. 1503, doi. 10.1111/bcp.16046

By:

Clewe, Oskar;
Rekić, Dinko;
Quartino, Angelica L.;
Carlsson, Björn;
Higashimori, Mitsuo;
Wernevik, Linda;
Hofherr, Alexis;
Rydén‐Bergsten, Tina;
Nilsson, Catarina;
Knöchel, Jane

Publication type:

Article

Verinurad does not prolong QTc interval: a thorough QT study using concentration–QTc modelling.

Published in:

British Journal of Clinical Pharmacology, 2023, v. 89, n. 6, p. 1747, doi. 10.1111/bcp.15637

By:

Parkinson, Joanna;
Dota, Corina;
Källgren, Christian;
Gottfridsson, Christer;
Bjursell, Magnus;
Perl, Shira;
Kӧrnicke, Thomas;
Rekić, Dinko;
Johansson, Susanne

Publication type:

Article

AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 11, p. 4839, doi. 10.1111/bcp.15425

By:

Rekić, Dinko;
Azarov, Ivan;
Knöchel, Jane;
Sokolov, Victor;
Nilsson, Catarina;
Wernevik, Linda;
Han, David;
Rydén‐Bergsten, Tina;
Ebrahimi, Ahmad;
Dota, Corina;
Carlsson, Björn

Publication type:

Article

Concentration‐QT modelling in early clinical oncology settings: Simulation evaluation of performance.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 3, p. 1010, doi. 10.1111/bcp.15047

By:

Cantet, Gael;
Berges, Alienor;
O'Sullivan, Rhianna;
Cohen‐Rabbie, Sarit;
Dota, Corina;
Dubois, Vincent;
Benoist, Guillemette E.;
Tomkinson, Helen;
Rekić, Dinko;
Parkinson, Joanna;
Schalkwijk, Stein

Publication type:

Article

Concentration‐QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 2, p. 858, doi. 10.1111/bcp.15006

By:

Voronova, Veronika;
Cullberg, Marie;
Delff, Philip;
Parkinson, Joanna;
Dota, Corina;
Schiavon, Gaia;
Maroj, Brijesh;
Rekić, Dinko;
Cheung, S. Y. Amy

Publication type:

Article

Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data.

Published in:

PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0269970

By:

Aoki, Yasunori;
Cabrera, Claudia S.;
Ouwens, Mario;
Bamberg, Krister;
Nyström, Jenny;
Raz, Itamar;
Scirica, Benjamin M.;
Hamrén, Bengt;
Greasley, Peter J.;
Rekić, Dinko

Publication type:

Article

Toxicokinetics of Mercury after Long-Term Repeated Exposure to Thimerosal-Containing Vaccine.

Published in:

Toxicological Sciences, 2011, v. 120, n. 2, p. 499, doi. 10.1093/toxsci/kfr009

By:

Barregard, Lars;
Rekić, Dinko;
Horvat, Milena;
Elmberg, Lisa;
Lundh, Thomas;
Zachrisson, Olof

Publication type:

Article

Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight.

Published in:

Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 319, doi. 10.1007/s40262-020-00943-6

By:

Rekić, Dinko;
Johansson, Susanne;
Leander, Jacob

Publication type:

Article